SARS-CoV-2-specific T lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SARS-CoV-2-specific T lymphocytes, covering 2022-11-23 to 2022-11-23. Get the full timeline:
Most recent: Clinical Trial Update: Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 Patients [Phase 1, Phase 2]